Development of a risk score for colorectal cancer screening
Gastroenterology and Hepatology from Bed to Bench,
Vol. 18 No. 3 (2025),
26 August 2025
https://doi.org/10.22037/ghfbb.v18i3.3140
Abstract
Aim: The aim of this study was to develop a simple and reliable scoring system for colorectal cancer risk assessment considering the effectiveness of different screening options.
Background: Colorectal cancer (CRC) is one of the leading causes of cancer-related mortality worldwide. As a preventable disease, accurate risk assessment plays a critical role in early detection and prevention strategies.
Methods: This study analyzed data from 3,465 individuals, including patients, first-degree, second-degree, and third-degree relatives of patients, and volunteers participating in a national CRC screening program. The dataset reflects nine years of prevention efforts targeting at-risk populations. Machine learning algorithms—Logistic Regression, Naïve Bayes, Neural Networks, Random Forest, and Support Vector Machines (SVM)—were applied to the data. Model performance was evaluated using cross-validation, ROC curves, F1 score, classification accuracy (CA), and overall accuracy metrics.
Results: Of the 3,465 participants, 2,240 were diagnosed with colorectal cancer, 60 were relatives of affected patients, and 1,086 were non-patient relatives. Among CRC patients, 1,979 were over the age of 40. Logistic Regression and Naïve Bayes achieved the highest AUC values (0.910 and 0.907, respectively), with corresponding accuracies of 84.5% and 82.8%. Logistic Regression demonstrated the highest overall accuracy. The proposed scoring system incorporated variables such as age, sex, diabetes, inflammatory bowel disease (IBD), smoking, alcohol consumption, tobacco use, BMI, family history, and five key symptoms: rectal bleeding, abdominal pain, unintended weight loss, changes in bowel habits, and anemia. The highest score was assigned to individuals over 60 years of age, while a score of 2 was allocated for a family history involving more than two affected relatives.
Conclusion: A scoring system based on easily measurable variables offers a practical and efficient tool for widespread clinical use. Such systems can assist healthcare professionals in streamlining risk assessment and improving early identification of high-risk individuals.
- Risk Score, Colorectal Cancer, Screening
How to Cite
References
Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 2023;72:338-44.
Sninsky JA, Shore BM, Lupu GV, Crockett SD. Risk factors for colorectal polyps and cancer. Gastrointest Endosc Clin N Am 2022;32:195-213.
Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol 2021;116:458-79.
Kastrinos F, Kupfer SS, Gupta S. Colorectal cancer risk assessment and precision approaches to screening: brave new world or worlds apart? Gastroenterology 2023;164:812-27.
Abbaszadegan MR, Moghbeli M. Genetic and molecular origins of colorectal Cancer among the Iranians: an update. Diagn Pathol 2018;13:1-13.
Roshandel G, Ferlay J, Ghanbari‐Motlagh A, Partovipour E, Salavati F, Aryan K, et al. Cancer in Iran 2008 to 2025: recent incidence trends and short‐term predictions of the future burden. Int J Cancer 2021;149:594-605.
Maserat E, Safdari R, Aghdaei HA, Zali MR. Designing evidence based risk assessment system for cancer screening as an applicable approach for the estimating of treatment roadmap. BMJ Open 2017;7:bmjopen-2016-015415.43.
Maserat E. Integrated colorectal cancer screening based on decision support information system. J Clin Res Paramed Sci 2024;13:e145700.
Zali MR, Safdari R, Maserat E, Aghdaei HA. Designing clinical and genetic guidelines of colorectal cancer screening as an effective roadmap for risk management. Gastroenterol Hepatol Bed Bench 2016;9:S53.
Maratt JK, Imperiale TF. Using online colorectal cancer risk calculators to guide screening decision-making. Am J Med 2023;136:308-14.
Kong Y, Zhuo L, Dong D, Zhuo L, Lou P, Cai T, et al. Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population. BMC Cancer 2022;22:961.
Peng L, Weigl K, Boakye D, Brenner H. Risk scores for predicting advanced colorectal neoplasia in the average-risk population: a systematic review and meta-analysis. Am J Gastroenterol 2018;113:1788-800.
Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M. Colorectal cancer. Lancet 2019; 394:1467–80.
Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent 2022;2:1‑9.
Sekiguchi M, Kakugawa Y, Ikematsu H, Hotta K, Konda K, Tanaka Y, et al. Risk stratification score improves sensitivity for advanced colorectal neoplasia in colorectal cancer screening: the Oshima study workgroup. Clin Transl Gastroenterol 2021;12:e00319.
Erdem L, Akbal E, Koçak E, Tucer D, Üçbilek E, Uyanıkoğlu A, et al. A new risk-scoring system for colorectal cancer and polyp screening by Turkish colorectal cancer and polyp study group. Turk J Gastroenterol 2022;33:286.
Selvachandran S, Hodder R, Ballal M, Jones P, Cade D. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 2002;360:278-83.
Mayor S. Simple risk score for colon cancer identifies people likely to benefit from colonoscopy. BMJ 2015;351:h4323.
- Abstract Viewed: 186 times
- PDF Downloaded: 121 times